Sorafenib-related adverse effects as prognostic markers in patients with hepatocellular carcinoma receiving transarterial chemoembolization and sorafenib therapy: A systematic review and meta-analysis
Enhanced The Role of MicroRNAs as Biomarker over Alpha-Fetoprotein in Hepatitis C Virus-Associated Hepatocellular Carcinoma: A Systematic Review and Bioinformatic Analysis